Skip to main content

Table 1 Clinical characteristics of individual (A) paediatric and (B) adult patients

From: Ecological patterns and processes of temporal turnover within lung infection microbiota

 

Ageb

Sex

CFTR Genotype1

CFTR Genotype2

CF-related diabetes

Pancreatic insufficiency

%FEV1c

SD

Exacerbationsd

(A)

 201a

12

Female

F508del

G551D

No

Insufficient

84.4

2.7

3

 203

6

Female

F508del

F508del

No

Insufficient

100.2

10.7

1

 212

9

Female

F508del

F508del

No

Insufficient

83.9

6.3

4

 213

6

Male

F508del

F508del

No

Insufficient

82.3

15.7

3

 216

9

Female

SN549N

SN549N

No

Insufficient

117.8

5.2

1

 217

8

Male

F508del

G542X

No

Insufficient

100.4

2.7

0

 218

11

Male

F508del

F508del

No

Insufficient

89.6

6.6

2

 219

8

Male

F508del

R56OT

No

Insufficient

98.7

1.4

0

 223

8

Male

F508del

S1235R

No

Sufficient

110.0

1.7

0

 228

6

Male

F508del

R553X

No

Insufficient

99.8

6.2

0

 233

15

Male

F508del

F508del

No

Insufficient

71.2

9.9

1

 240

11

Female

F508del

F508del

No

Insufficient

60.6

6.3

1

 242a

6

Female

F508del

G551D

No

Insufficient

74.7

8.6

2

 245

6

Male

F508del

F508del

No

Insufficient

92.0

14.2

3

 246

9

Female

3849 + 10kbC > T

3849 + 10kbC > T

No

Sufficient

91.0

9.1

2

(B)

 101

22

Male

R334W

R75X

No

Sufficient

64.2

2.1

7

 103

22

Male

F508del

3849 + 10kbC > T

No

Sufficient

79.7

7.9

1

 104

28

Male

3849 + 10kbC > T

3849 + 10kbC > T

No

Sufficient

77.9

7.5

2

 106

19

Male

F508del

F508del

No

Insufficient

57.2

8.0

8

 108

35

Male

F508del

F508del

No

Insufficient

60.7

1.5

2

 110

28

Female

F508del

F508del

No

Insufficient

120.1

2.7

1

 112

24

Male

F508del

F508del

No

Sufficient

93.2

4.5

1

 113

21

Female

F508del

Delexon2-3

No

Insufficient

58.1

1.4

3

 114

21

Male

F508del

F508del

No

Insufficient

87.1

1.9

0

 116

24

Male

R117H

S549N

No

Sufficient

99.6

2.1

0

 118

25

Female

F508del

F508del

No

Insufficient

73.8

4.2

3

 119

20

Female

R553X

2622 + 1G- > A

Yes

Insufficient

47.9

2.9

3

 120

19

Male

F508del

F508del

No

Insufficient

78.6

3.3

0

 121

29

Male

F508del

R117H

No

Sufficient

92.9

3.7

1

 140

17

Male

F508del

2622 + 1G > A

No

Sufficient

47.3

6.9

6

  1. aPatients receiving Ivacaftor CF transmembrane conductance regulator (CFTR) modulator therapy
  2. bAge in years at the start of the study
  3. cMean lung function ± standard deviation (SD) over the course of the study
  4. dNumber of acute pulmonary exacerbations experienced over the course of the study